Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Showing posts with label NOT RECOVERY!. Show all posts
Showing posts with label NOT RECOVERY!. Show all posts

Wednesday, November 20, 2024

Covid's Long-term Impact on Stroke Rehab Unveiled - Australia

 Why would you want to return to pre COVID levels? They were a complete failure at getting 100% recovered anyways! Your tyranny of low expectations is showing. Nothing will get better in stroke until survivors are in charge, so start scaling the walls. Or you could wait until these persons become the 1 in 4 per WHO that has a stroke : they'll want 100% recovery then and by then it will be too late.

Covid's Long-term Impact on Stroke Rehab Unveiled

A Stroke Foundation audit of Australian hospitals has highlighted the 'concerning' long-term impact of COVID-19 on inpatient stroke rehabilitation services.

Released today, the 2024 audit found that structures and resourcing at one in five audited services have still not returned to pre-pandemic levels, four years on.(And those levels were complete failures in getting to 100% recovery, weren't they?)

Stroke Foundation Chief Executive Officer, Dr Lisa Murphy, says this needs to change.

"Appropriate resourcing on inpatient rehabilitation wards is critical to delivering the best possible care(NOT RECOVERY!) to all survivors of stroke across Australia so they can make the best recovery possible after stroke."

The audit looked at various ways COVID-19 impacted rehabilitation services, such as: a relocation, or reduction, in the number of rehabilitation beds, changes in the format of ward rounds and redeployment of staff.

Of the hospitals audited, 60 per cent recorded a reduction in the number of rehabilitation beds, 96 per cent recorded staff shortages, and 63 per cent recorded staff being redeployed to other duties, at the time of the pandemic.

"The pandemic was hugely demanding and put a significant strain on Australia's health system. While this led to a rapid innovation in services such as use of telehealth. We cannot accept that there are still stroke rehabilitation services that have not yet returned to optimal resources. We should not have the continued crisis within the rehabilitation services that this data suggests," Dr Murphy said.

The report highlights areas of improvement and will inform conversations and recommendations to government and health care providers.

"This will allow us to set priorities for governments, health care administrators and health care professionals as we move forward in the post-pandemic era and strive for equitable access to appropriate, specialised and adequately resourced rehabilitation services for stroke."

"It is time to fill the critical gaps, view rehabilitation as an important next step in the patient's treatment journey and shift the focus from surviving to thriving."

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.           

Monday, November 18, 2024

In-hospital stroke care provision has not improved enough over the last 10 years, says the Stroke Association

 The whole problem here is measuring 'care' NOT RECOVERY! Until you get survivors in charge nothing will change for the better. SO, GET TO WORK AND TAKE OVER THE STROKE ASSOCIATION!    

The only goal in stroke is 100% recovery, so start creating a strategy to GET THERE!

In-hospital stroke care provision has not improved enough over the last 10 years, says the Stroke Association

Thousands of stroke patients are missing out on lifechanging treatment and support as vital elements of in-hospital stroke care(NOT RECOVERY!) have declined over the last decade amidst increased waiting times, warns the Stroke Association.

Despite promising progress in some vital areas and the dedication of an overstretched workforce, the current healthcare ecosystem doesn’t appropriately support the 90,000 people who survive stroke every year to recover and live well afterwards.

The latest figures from the Sentinel Stroke National Audit Programme (SSNAP)1 reveal how both innovative treatments, such as thrombectomy, and basic care(NOT RECOVERY!) , such as hospital rehabilitation, are still being delivered inconsistently throughout the country.

SSNAP data found some basics in acute stroke care(NOT RECOVERY!)  are now worse than they were 10 years ago. The number of people directly admitted to a specialist stroke unit within four hours of arrival at hospital stood at 46.7% in 2023/24 but 54.9% in 2019/20 before the pandemic and 58% in 2013/14. This time spent waiting dramatically increases the risk of stroke survivors facing long-term poor health and disabilities.

In addition, the number of patients spending more than 90% of their time on a specialist stroke unit when admitted to hospital has decreased in the last five years from 83.2% in 2019/20 to 75.9% in 2023/24 - which represents a drop of more than 4,400 patients. This specialist support is key to helping reduce mortality within the first 30 days and optimising stroke recovery.2

There has been an increase in people receiving integrated community-based rehabilitation, which is the preferred option for patients, and a key factor in NHS reform. However, the amount of time being spent delivering occupational therapy, physiotherapy and speech and language therapy has notably decreased over the last five years. Compounded by cuts to life-after-stroke support services, these types of care(NOT RECOVERY!)  are vital to ensure stroke survivors can thrive throughout their recovery and beyond.

Although there have been significant improvements in moving patient rehabilitation from the acute sector and into the community, such support is still falling well below the 2023 National Institute for Health and Care Excellence (NICE) guidelines.3

The SSNAP data also comes alongside the latest figures from NHS England which reveal that ambulance response times for Category 2 calls, which includes stroke, increased to 42 minutes and 15 seconds in October from 36 minutes and 2 seconds in September. This is above the 30-minute target set out in the NHS England Urgent and Emergency Care Plan and at a time when the NHS experienced more pressure in October than ever before on record.

This is contributing to how people affected by stroke are taking longer to arrive at hospital from onset – the average time has increased by almost a third to nearly 250 minutes since 2013/14. Speedy treatment of stroke is crucial as 1.9 million brain cells die every minute that a stroke is left untreated, increasing the risk of serious long-term disability and even death.

Although the stroke community has improved the use of thrombectomy4 treatment - from less than 1% in 2015/16 when such data was first collated - SSNAP data shows that 3.9% of stroke patients had a thrombectomy last year. With NHS England’s target at 10% by 2027/28, this is still falling behind and there are continued regional disparities.

Similarly, thrombolysis5, a clot-busting drug, is underused. Around 20% of stroke patients are eligible for the treatment but only an average of 11.6% patients received the treatment in 2023/24 against the NHS England target of 20% by 2025 to achieve the best performance in Europe. There has been little or no variation over the last 10 years, but a sharp decline at the height of the pandemic.

The Stroke Association is calling on the Government for the 10 Year Health Plan to:

  • Invest in stroke prevention, such as regular blood pressure checks, so many of the 100,000 strokes which happen every year can be prevented.
  • Support the delivery of universal 24/7 access to an acute stroke unit and stroke treatments, such as thrombectomy and thrombolysis
  • Support in-hospital and community rehabilitation services so that stroke survivors can live well after stroke.

Juliet Bouverie OBE, Chief Executive of the Stroke Association, said: “Despite a dedicated workforce with expert knowledge on how to help and support stroke survivors to make their fullest recoveries, the NHS stroke pathway has long been at crisis point. The recoveries of too many stroke survivors are being put at risk due to a lack of staff, spiraling waiting times and a lack of basic stroke care(NOT RECOVERY!)  provision which compromises - rather than optimises - patient recovery.

“Patients have been battling what feels like a permacrisis in our healthcare which has been blighting NHS care(NOT RECOVERY!)  for long enough – governmental change is long overdue, and the 10 Year Health Plan is an ideal opportunity to ensure everyone who has a stroke can survive and live well.”

The Stroke Association supports thousands of stroke survivors and their families by phone, at home, and in the community. Find out more at www.stroke.org.uk

Case Studies

Chloe Hodgkisson from Cambridgewas 37 when she had a stroke whilst on a holiday in Oxford with her husband, Ben, and their young family. She woke up early feeling faint, dizzy, and with an awful headache. She soon began experiencing sickness, reduced mobility, blurred vision, difficulty speaking and her face dropped on one side.

Ben called 111 and, following a telephone assessment, an ambulance arrived 10 minutes later. Chloe was taken to the John Radcliffe Hospital in Oxford where an MRI confirmed her diagnosis, and she had an urgent thrombectomy.

She said: “I instantly felt better after waking up from the surgery – I could speak, I could see, I could move my arms and legs – I was so relieved to have a conversation with my family again. Having a stroke stops your life completely and the recovery process gets the wheels moving again. It’s hard to explain to people who haven’t had a stroke or aren’t trained to understand it, but the trauma of it doesn’t ever go away.”

Phil Woodford, 53, from Preston had a TIA – a type of mini stroke – and full stroke the next day eight years ago. He was given thrombolysis, but he was unable to have a thrombectomy because his local hospital didn’t - and still doesn’t - provide the service on a weekend.

Phil said: "My life changed overnight. It took four months' rehabilitation in hospital and then another four months until I could return to work. My stroke caused musculoskeletal problems, permanent pain and weight gain because I'm less mobile now. I walk with a limp and my left arm sometime moves on its own and suffers from spasticity and cramps. Whilst there's no guarantee, if I had a thrombectomy, then I may well not have to be living with these disabilities."


Declining standards of care for stroke patients must be reversed, says charity - UK

 Wrong focus. Survivors don't care about 'care'! They want 100% recovery. Where is it? You'll have to put survivors in charge of this charity(Stroke Association) and get the correct objectives for it.

Declining standards of care for stroke patients must be reversed, says charity

Figures from audit of England, Wales and Northern Ireland show some basic care now worse than decade ago

Sun 17 Nov 2024 19.01 EST

Ministers are being urged to improve declining care(NOT RECOVERY!) for stroke patients to lower the risk of death and disability as new figures show rising cases, especially among people in their 50s.

Thousands of stroke patients are missing out on appropriate treatment and rehabilitation, the standards of which have worsened over the past decade, the Stroke Association has said as it publishes the latest figures from the Sentinel Stroke National Audit Programme (SSNAP), the nation’s biggest stroke data audit covering England, Wales and Northern Ireland.

Separate NHS England analysis paints a picture of a healthcare system under increasing strain, as the number of people being admitted to hospital after a stroke has risen by 28% in the last 20 years. This included a 55% rise in admissions among people aged 50-59, bringing the number to 12,533 in 2023-24 – the highest increase among any age group. The rise is understood to be fuelled by obesity, poor diet and sedentary lifestyles.

The Stroke Association said that innovative treatments, such as thrombectomy, and basic care(NOT RECOVERY!), such as hospital rehabilitation, are still being delivered inconsistently across different regions.

Juliet Bouverie, the chief executive of the Stroke Association, said: “The NHS stroke pathway has long been at crisis point. The recoveries of too many stroke survivors are being put at risk due to a lack of staff, spiralling waiting times and a lack of basic stroke care(NOT RECOVERY!) provision which compromises – rather than optimises – patient recovery.

“Governmental change is long overdue, and the 10-year health plan is an ideal opportunity to ensure everyone who has a stroke can survive and live well.”

SSNAP data found that some basics in acute stroke care(NOT RECOVERY!) are now worse than they were 10 years ago. The percentage of people directly admitted to a specialist stroke unit within four hours of arrival at hospital stood at 46.7% in 2023-24, compared with 58% in 2013-14. Extra time spent waiting dramatically increases the risk of long-term poor health and disabilities.

The percentage of patients spending more than 90% of their time on a specialist stroke unit when admitted to hospital has decreased in the last five years from 83.2% in 2019-20 to 75.9% in 2023-24, a drop of more than 4,400 patients.

The latest figures from NHS England reveal that ambulance response times for category 2 calls, which includes stroke, have increased to 42 minutes and 15 seconds in October from 36 minutes and 2 seconds in September, meaning they arrive later at hospital, causing 1.9m brain cells to die every minute that a stroke is left untreated.

SSNAP data also shows that 3.9% of stroke patients had a thrombectomy last year, well below NHS England’s target of 10% by 2027-28. Although about 20% of stroke patients are eligible for thrombolysis, a treatment to dissolve blood clots, only an average of 11.6% patients received it in 2023-24.

The Stroke Association is calling on the government to invest in stroke prevention, such as regular blood pressure checks; support the delivery of universal 24/7 access to an acute stroke unit and stroke treatments such as thrombectomy and thrombolysis; and provide more funding for in-hospital and community rehabilitation services.

Eight years ago Phil Woodford, 53, from Preston, had a transient ischaemic attack (TIA) – a type of mini stroke – and full stroke the next day. He was given thrombolysis, but he was unable to have a thrombectomy because his local hospital did not provide the service on a weekend, which he believes may have ruined his quality of life.

He said: “My life changed overnight. It took four months’ rehabilitation in hospital and then another four months until I could return to work. My stroke caused musculoskeletal problems, permanent pain and weight gain because I’m less mobile now. I walk with a limp and my left arm sometime moves on its own and suffers from spasticity and cramps.”

A Department of Health and Social Care spokesperson said: “It is unacceptable that so many stroke survivors are not receiving the support and care(NOT RECOVERY!) they need with their recovery. We are committed to improving stroke prevention, treatment and recovery for all stroke survivors.

“We have introduced health checks in workplaces and blood pressure checks on high streets to help catch illness earlier, and we’re also acting to prevent strokes in the first place by tackling the biggest killers such as smoking and obesity.

“We will deliver the investment and reform needed to turn the NHS around, which includes shifting the focus of healthcare from treatment to prevention, as part of our 10-year health plan.

Monday, November 11, 2024

First prospective Indian thrombectomy registry shows high revascularisation rates and confirms procedure is cost effective

 This shows the tyranny of low expectations from the beginning. Survivors want 100% recovery, not just the first step of revascularization! You'll have to start screaming at these people if you want something better than this crapola!

First prospective Indian thrombectomy registry shows high revascularisation rates and confirms procedure is cost effective

Data from a registry claimed to be the first prospective registry on mechanical thrombectomy for stroke in India has revealed a number of key insights on how this treatment is being implemented across the country. High revascularisation rates and good functional outcomes(NOT RECOVERY!), as well as workflow metrics that are “comparable” with those seen in other geographies, are among researchers’ most notable findings.

Presenting these data from the Indian PRAAN registry at the 16th World Stroke Congress (WSC; 23–26 October, Abu Dhabi, United Arab Emirates), Jeyaraj Pandian (Christian Medical College and Hospital, Ludhiana, India)—who recently became the World Stroke Organization (WSO) president—and WSO board of directors member P N Sylaja (Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, India) initially highlighted the low overall utilisation of stroke thrombectomy in India. They cited high procedure costs, a lack of sufficient numbers of interventionists, and availability of only a few cath labs in the country, as the main drivers of this.

“With the current incidence of stroke [in India], we need to do more than 100,000 thrombectomies in a year—but we are doing fewer than 3,000–4,000,” Sylaja said, speaking to NeuroNews.

With this in mind, the prospective, multicentric, observational PRAAN registry was set up with the intention of studying patient characteristics, systems of care and functional outcomes associated with thrombectomy treatment in Indian patients with large vessel occlusion (LVO) acute ischaemic stroke.

More specifically, the registry includes stroke patients treated with the Solitaire X revascularisation device and/or the React catheter (both Medtronic) as the primary devices used. It has enrolled patients undergoing thrombectomy with stroke onset less than 24 hours from time last known well; Alberta stroke programme early computed tomography score (ASPECTS) >5; core infarct volume <70ml on non-contrast CT (NCCT) or diffusion-weighted magnetic resonance imaging (DW-MRI); and National Institutes of Health stroke scale (NIHSS) scores ≥6. An independent core lab and clinical events committee (CEC) assessed patient outcomes in the registry.

Pandian and Sylaja reported that, from August 2021 to October 2023, 200 patients were enrolled at 14 sites—of which 190 patients with an average age of just under 60 years met the eligibility criteria for PRAAN. The investigators relayed that, of these patients, 131 were treated using the Solitaire stent retriever, 19 were treated via aspiration thrombectomy using the React catheter, and 40 received a combined approach involving both Solitaire and aspiration. They also found that the majority of LVOs included in the study (55.3%) were M1 occlusions in the middle cerebral artery (MCA).

Pandian, Sylaja and colleagues ultimately found that these 190 patients experienced a median door-to-groin-puncture time of 99 minutes (range, 11–478), as well as a median groin-puncture-to-revascularisation time of 40 minutes (range, 10–170). In addition—and perhaps even more notably—the rate of successful revascularisation characterised by a modified thrombolysis in cerebral infarction (mTICI) grade ≥2b was 90.7% across a total of 184 patients, while functional independence defined as a 90-day modified Rankin scale (mRS) score of 0–2 was 65.8% based on a cohort of 187 patients.

Regarding more safety-centric outcome measures, the investigators observed a 2.1% rate of symptomatic intracranial haemorrhage (sICH) and a 6.3% rate of all-cause mortality across the full population of 190 patients.

Finally, Pandian and Sylaja reported that the majority of the 190 patients in the present registry (80%) were discharged home following their thrombectomy procedures and also relayed that—while the treatment is expensive—it was found to be cost effective overall.

“In spite of all the barriers to acute stroke treatment in India, this prospective registry was able to show that the performance metrics of [thrombectomy] and the functional outcomes at 90 days were similar to what has been reported globally(DON'T COMPARE YOURSELF TO GLOBAL FAILURES IN STROKE!),” Sylaja told NeuroNews. “Although this treatment is expensive, it is cost effective. This highlights the need of having more endovascular thrombectomy centres in India, and government reimbursement of this treatment, so that it will be available to all. Since LVO in acute ischaemic stroke leads to severe strokes, this life-saving treatment can reduce the burden of disability due to stroke.”

On a similar note, Pandian stated that, in his view, the main take-home message from this registry should be the positive patient outcome data, which are better than many previously reported figures.

New national standards

Also presenting at WSC 2024 was Kashipa Harit (Quality Council of India, Delhi, India), who cited data from a recent Global Burden of Diseases (GBD) study to emphasise the burden of stroke in India—including high rates of incidence (68.6%), deaths (70.9%) and disability-adjusted life years lost (77.7%).

Harit relayed that, back in November 2022, India’s National Accreditation Board of Hospitals and Healthcare Providers (NABH) signed a memorandum of understanding with the WSO to launch a national stroke centre certification programme, with the ultimate goal of helping to deliver consistent and effective treatments, improve patient outcomes, and reduce care variations.

A systematic questionnaire aligned with NABH and WSO standards has been used in an attempt to establish these national standards. According to Harit, it assesses five clinical and five non-clinical aspects of stroke care(NOT RECOVERY!). These aspects include access; assessment and continuity of care(NOT RECOVERY!); care of patients; management of medication; patient rights and education; infection control, patient safety and quality improvement; responsibilities of management; facility management and safety; human resource management; and information management systems.

Once established, the standards will be applied to stroke centres in order to investigate their effectiveness in greater detail. Harit reported that the standards seek to provide requirements that are “quantifiable, reasonable and feasible for centres” in optimising patient outcomes, minimising medical errors, and fostering a culture of continuous quality improvement. She also noted that the standards “hold promise for mitigating the burden of stroke in India” and improving the nation’s overall quality of healthcare delivery.

Saturday, November 9, 2024

Citizens Memorial Hospital receives Acute Stroke Ready Center certification from DNV

 

Survivors don't care about your 'care'; you FUCKING BLITHERING IDIOTS; they want 100% recovery! Why aren't you providing that?

Big fucking whoopee.

 

 But you tell us NOTHING ABOUT RESULTS. They remind us they 'care' about us multiple times but never tell us how many 100% recovered.  You have to ask yourself why they are hiding their incompetency by not disclosing recovery results.  ARE THEY THAT FUCKING BAD?


Three measurements will tell me if the stroke medical world is possibly not completely incompetent; DO YOU MEASURE ANYTHING?  I would start cleaning the hospitals by firing the board of directors, you can't let incompetency continue for years at a time.

There is no quality here if you don't measure the right things.

  1. tPA full recovery? Better than 12%?
  2. 30 day deaths? Better than competitors?
  3. rehab full recovery? Better than 10%?

 

You'll want to know results so call that hospital president(whomever that is) RESULTS are; tPA efficacy, 30 day deaths, 100% recovery. Because there is no point in going to that hospital if they are not willing to publish results.

In my opinion this certification allows stroke hospitals to continue with their tyranny of low expectations and justify their complete failure to get survivors 100% recovered. Prove me wrong, I dare you in my stroke addled mind. If your stroke hospital goal is not 100% recovery you don't have a functioning stroke hospital.

 

All you ever get from hospitals are that they are following guidelines; these are way too static to be of any use. With thousands of pieces of stroke research yearly it would take a Ph.D. level research analyst to keep up, create protocols, and train the doctors and therapists in their use. 

If your stroke hospital doesn't have that, you don't have a well functioning stroke hospital, you have a dinosaur. 

Read up on the 'care' guidelines yourself. Survivors want RECOVERY not 'care'

“What's measured, improves.” So said management legend and author Peter F. Drucker 

The latest invalid chest thumping here:

Citizens Memorial Hospital receives Acute Stroke Ready Center certification from DNV

Citizens Memorial Hospital has received certification from DNV as an Acute Stroke Ready Center, recognizing its ability to handle strokes and stroke-related medical problems. CMH is also a designated Level III Stroke Center by the Missouri Department of Health and Senior Services.

Through a partnership with CoxHealth, CMH offers 24/7 telestroke coverage. This service connects CMH patients to neurologists at Cox South, the region's only DNV-certified Comprehensive Stroke Center. This allows treatment to begin within minutes of a patient's arrival at the hospital.

The Acute Stroke Ready certified program is especially important for communities where access to a larger hospital may be too far away.

“We know that ‘time is brain,’ and the faster a patient can get to a certified stroke center, the better,” says Sarah Bolton, Time Critical Diagnosis program manager at CMH. “This certification shows that we have the resources and dedication to provide the best possible stroke care(NOT RECOVERY!).”

When a patient arrives at CMH with stroke-like symptoms such as balance issues, vision loss, uneven smile, arm weakness, or slurred speech, emergency room staff act fast. They perform advanced brain scans and consult with neurologists at CoxHealth.

For patients who are eligible, tenecteplace (TNK), a medication to treat blood clots, must be given within a short window of time. Quick action is critical, which is why calling 911 right away when symptoms appear is essential.

“It’s a combination of the right equipment, personnel and training to quickly assess, identify and treat strokes,” Bolton said. “This certification validates the tremendous effort we have put into this program, ensuring the health and safety of our patients.”

The DNV Acute Stroke Ready Certification is based on standards from the Brain Attack Coalition and the American Stroke Association. It affirms that CMH provides initial diagnosis and treatment and, when necessary, quickly transfers patients to a specialized stroke center with a higher spectrum of stroke care(NOT RECOVERY!).

“Achieving certification shows a commitment to excellence,” says Kelly Proctor, president of DNV Healthcare USA Inc. “It helps demonstrate to your community that you are providing the highest level of care(NOT RECOVERY!) that this hospital is designed to offer.”

Stroke is a leading cause of death in the U.S., claiming nearly 130,000 lives each year, according to the American Stroke Association. It also causes serious, long-term adult disabilities. Quick treatment can save lives and limit long-term damage.

For more information about DNV, visit https://www.dnv.us/supplychain/healthcare/stroke-certs/.

About CMH

Citizens Memorial Hospital is a comprehensive rural healthcare system in Bolivar, Missouri, serving eight counties. CMH is an 86-bed acute care(NOT RECOVERY!) hospital and a Level III Trauma Center, Level II STEMI Center and Level III Stroke Center. In addition to hospital services, CMH includes 34 physician clinics, rehabilitation services, and ambulance services in four counties.

The CMH Foundation operates six long-term care facilities and a residential care center, retail pharmacies, an array of home care(NOT RECOVERY!) and hospice services, home medical stores, and a senior health center.

Currently, Citizens Memorial Hospital is undergoing a 117,000-square-foot expansion and a 25,000-square-foot renovation project that will enhance patient care(NOT RECOVERY!) with private rooms. The project is scheduled for completion in 2026.

Thursday, November 7, 2024

Researching trends on stroke: bibliometric analysis of the highly cited papers

 Recovery isn't even in the top 25 keywords in stroke research; THAT'S HOW FUCKING BAD THE STROKE MEDICAL WORLD IS! Doing NOTHING FOR SURVIVORS! Which is why we need survivors in charge. They'll change their minds after they become the 1 in 4 per WHO that has a stroke : and by then it will be too late.

Send me hate mail on this: oc1dean@gmail.com. I'll print your complete statement with your name and my response in my blog. Or are you afraid to engage with my stroke-addled mind? I would like to know exactly where my analysis is wrong.

Researching trends on stroke: bibliometric analysis of the highly cited papers

\r\nLi Fan,Li Fan1,2Fuyan ShiFuyan Shi1Suzhen Wang
Suzhen Wang1*
  • 1Department of Health Statistics, School of Public Health, Shandong Second Medical University, Weifang, Shandong, China
  • 2People's Hospital of Ningxia Hui Autonomous Region, Yinchuan, Ningxia, China

This study assessed the progression of stroke using bibliometric methods. By March 31, 2024, highly cited papers on stroke were collected from the Web of Science Core Collection. Collaboration and keyword conjunction analyses, along with their visual representations, were conducted using VOSviewer. CiteSpace was employed to identify keywords and reference sources. A comprehensive review of 2,509 highly cited studies on stroke was conducted. Notably, the United States, China, and the United Kingdom have emerged as leading contributors to this research domain, with the New England Journal of Medicine having the highest number of publications. YUSUF S had the highest H-index among all authors. The key terms frequently encountered were “stroke,” “atrial fibrillation,” and “cardiovascular disease.” This study performed a detailed bibliometric review of stroke research over the past decade, shedding light on the participation of various countries, organizations, authors, journals, and articles in the field. These insights offer a broad snapshot of the global stroke research trends.

1 Introduction

Owing to the high frequency, prevalence, disability rate, and mortality rate of stroke, it has received widespread attention from the global research community (GBD 2019 Stroke Collaborators, 2021). There is a large amount of scholarly literature on stroke, and numerous studies have been published in leading medical journals. Many researchers have conducted comprehensive meta-analyses to examine the various factors related to stroke. However, systematic bibliometric examinations providing a comprehensive view of publications, countries, research institutions, journals, authors, and keywords in published formats are lacking. This bibliometric study aims to fill this gap by providing a detailed and insightful overview of the existing knowledge in stroke research. Bibliometrics is an analytical discipline that uses quantitative and statistical methods to study the production and dissemination of scholarly literature (Hicks et al., 2015). It involves careful collection, organization, and analysis of bibliographic data such as citation counts, co-authorship networks, and publication venues (Mukherjee et al., 2022). The advantages of bibliometrics include their ability to quantify and identify the impact of research, provide evidence-based evaluations of scientific output, and track the progress and influence of research over time. It also helps to identify emerging trends, developing fields, collaborative efforts, and guide strategic planning and resource allocation within research institutions (Jiang et al., 2023). With the expanding volume of scientific literature and growing importance of research impact, the role of bibliometrics in evaluating and interpreting research has become increasingly important.

This study used a comprehensive bibliometric analysis to assess the trajectory, breakthroughs, and key issues within the existing stroke research. By summarizing and analyzing current findings and trends, this study fills critical gaps in the existing literature, providing researchers, clinicians, epidemiologists, and policymakers with a refined and comprehensive perspective on the current state of stroke research.

2 Materials and methods

2.1 Data retrieval strategies

We used the Web of Science Core Collection (WoSCC), the most authoritative and comprehensive global science database, to search for stroke-related literature. The search spanned articles uploaded to the database on March 31, 2024. The search terms were as follows: ((((((TS = (stroke)) OR TS = (cerebral infarction)) OR TS = (ischemic stroke)) OR TS = (intracerebral hemorrhage)) OR TS = (hemorrhagic stroke)) OR TS = (subarachnoid hemorrhage)). Because of the absence of animal testing or experimental protocols in our study, ethical clearance was not required. Our selection criteria were confined to Highly Cited Papers with document types of “article” or “review” in the English language, targeting a specific subject matter and research objective, and ensuring uniformity in language for subsequent analysis. All other literature types and non-English articles were excluded from the review. We conducted searches and examined all articles retrieved in various formats on the same day in plain text form to create master files for use with different bibliometric tools (Yeung, 2019). Thereafter, we extracted essential information such as author names, source of study, title, keywords, and cited references from the exported articles to mitigate potential errors during retrieval at different instances.

2.2 Bibliometric analysis

In this study, we employed R version 4.3.3 (Ihaka and Gentleman, 1996), VOSviewer (Van Eck and Waltman, 2010), and CiteSpace (Chen, 2006) to conduct bibliometric analysis. We utilized the Bibliometrix R package version 4.3.3 to calculate the frequency of international collaboration among countries (Aria and Cuccurullo, 2017). VOSviewer was used to determine the numbers of publications, citations, and keywords. The built-in clustering algorithm of the software enabled the construction and visualization of co-occurrence networks of key terms from scientific literature (Jiang et al., 2022). Our main focus was on co-authorship and co-occurrence analysis, which helped us to understand the collaboration between countries, institutions, and authors.

We used CiteSpace to identify highly cited references and keywords that had witnessed substantial citation growth over a specific period. Using online bibliometrics, we visualized international collaborations between countries. We analyzed the annual scientific output and average citations per year using Microsoft Excel.

3 Results

3.1 Overview of publication status

From the extensive collection of 332,408 research studies, a selected group of 2,509 publications that had been extensively referenced was identified for closer analysis. This collection includes 1,749 articles and 760 reviews, as depicted in Figure 1. Figure 2 illustrates that the most recent of these highly cited papers on stroke were released in 2024, with the earliest being from 2013. A review of the most highly cited periodicals revealed that the annual volume of scientific contributions will reach its zenith in 2022. In addition, 2020 saw the highest annual average number of citations per paper.

Figure 1
www.frontiersin.org

Figure 1. Flow-chart of the study.

Figure 2
www.frontiersin.org

Figure 2. Annual scientific production and average citations per year.

3.2 Analysis of national publication counts

To explore the distribution of research output across countries and regions, a comprehensive analysis of national publication tallies was conducted (Figures 3A, B). The dataset reviewed included research contributions from 113 countries or regions and more than 5,186 distinct institutions. As depicted in Figure 3, the United States emerged as the leading contributor, with 906 published works, followed by China (283), the United Kingdom (268), Germany (140), and Canada (132). All other countries or regions included in the analysis had a total publication count of < 100.

Figure 3
www.frontiersin.org

Figure 3. (A) Country scientific production; (B) the output of top 10 countries; (C) the corresponding author's countries; (D) the country collaboration map.

In addition to the overall output analysis, we mapped international collaborations in the field of stroke research, as shown in Figure 3D. The findings revealed that the United States is at the forefront of stroke research collaborations. There is a high degree of global cooperation, particularly among the developed nations in Europe and North America (Figure 3C). The top 10 countries in terms of collaboration, the top 10 countries had a median country-to-country partnership (MCP) ratio exceeding 45% when collaborating with international authors. The United States collaborated the most in the United Kingdom (420 times), Canada (365 times), and Germany (323 times). In the United Kingdom, the most frequent collaborative partners were Germany (242 times) and Canada (241 times).

3.3 Analysis of institution publications

An analysis was conducted to examine the contributions of various institutions to the domain of stroke research, which revealed the publication output of nearly 5,186 institutions globally. As depicted in Figure 4, the five leading institutions published more than 100 papers, with Harvard Medical School emerging as the leader with 157 publications. Brigham and Women's Hospital closely followed the 124 publications. Additionally, to delve deeper into collaborative efforts between institutions, a co-authorship analysis was conducted across all published papers. As shown in Figure 5, 68 institutions had published at least 25 papers. These 85 institutions were clustered into four groups, with the red cluster being the most prominent, comprising 36 members, primarily from the USA. The green cluster was the second-largest cluster, consisting of 31 institutions. The third cluster is the blue cluster with nine institutions, and the smallest is the yellow cluster, which consists of eight institutions.

Figure 4
www.frontiersin.org

Figure 4. The top 10 institutions with the most publications in the field of stroke.

Figure 5
www.frontiersin.org

Figure 5. Research institute co-occurrence network.

3.4 Analysis of publication quantity and journal impact

This study included 2,509 articles published in 590 journals. Table 1 lists the top 10 journals ranked by publication quantity and latest 2022 impact factors (IF). The top 10 journals were all top journals, with an average impact factor of 73.13, and four journals had an influence factor of more than 100. All top 10 journals were in the first quartile (Q1) of the Journal Citation Reports (JCR). As shown in Figure 6, we can see from the graph of Bradford's dispersion law that the core journals in the research field include the top seven journals in terms of their publications.

Table 1
www.frontiersin.org

Table 1. Top 10 journals in the field of stroke.

Figure 6
www.frontiersin.org

Figure 6. Core sources by bradford's law in field of stroke.

3.5 Author impact analysis

A comprehensive analysis of 15,324 contributors to seminal stroke studies revealed that YUSUF S led the pack with 43 published studies and an H-index of 43. Second, GUPTA R and LIP GYH also deserve mention, producing 40 articles each, with an H-index of 39 (Table 2).

Table 2
www.frontiersin.org

Table 2. Top 10 authors in the highly cited papers in the field of stroke research.

The collaborative networks among these researchers are depicted in Figure 7, where the size of the nodes corresponds to the number of articles authored, and the color coding denotes the clusters. Eighty authors, each having published eight or more articles, were identified and organized into nine clusters. These clusters exhibit mutually cooperative patterns. The largest cluster comprised 14 research groups, whereas the smallest contained only four research groups.

Figure 7
www.frontiersin.org

Figure 7. Authors in stroke researches visualization.

3.6 Co-cited references

Over the past 10 years, 172,373 references have been cited in highly cited papers on stroke. To further explore the research dynamics and trends in this field, we identified 10 articles with the highest citation frequency (Table 3). In addition, 86 cited references were selected, and a co-citation network graph was generated with a threshold ≥30 (Figure 8). As shown in Figure 8, a positive co-citation relationship is observed among articles published in different years in the journals. There was one reference published in the New England Journal of Medicine in 2009 that has received the most citations: “Dabigatran vs. warfarin in patients with atrial fibrillation.” The results of this study demonstrate that anticoagulation with 110 mg dabigatran and warfarin is equivalent in patients with atrial fibrillation, with no significant difference in the risk of preventing stroke and systemic embolism. However, in patients receiving dabigatran, the risk of major bleeding was significantly lower than that in those receiving warfarin. When the dabigatran dose was increased to 150 mg, the risk of stroke and systemic embolism was significantly lower in the treatment group than that in the warfarin group, while the proportion of major bleeding remained stable (Connolly et al., 2009). This finding provides an important reference for anticoagulation therapy in patients with atrial fibrillation, showing the potential advantages of dabigatran. The lowest-cited reference was published in Lancet in 2014 (citation number: 63). The average citation value for the first 10 cited references was 70.7.

Table 3
www.frontiersin.org

Table 3. Top 10 co-cited references in highly cited papers in the field of stroke research.

Figure 8
www.frontiersin.org

Figure 8. Co-cited references in stroke researches visualization.

3.7 Analysis of citation bursts

The top 15 most-cited references are shown in Figure 9. A burst occurs when a publication receives a significantly higher number of citations than usual and lasts for at least 2 years (Jiang et al., 2022). The blue line represents the observation period from 2013 to 2024 and the red line indicates the burst time. The article “Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association,” published in the stroke, has the highest citation burst value (citation burst = 17.98) between 2013 and 2024. This is the latest citation outbreak in 2021 and has continued to date (Powers et al., 2019). The guidelines detail prehospital care, emergency evaluation, intravenous and intravenous treatment, and in-hospital management, including appropriately instituted secondary prevention measures within the first 2 weeks. The guidelines support the overall concept of a stroke care system and provide recommendations based on available evidence to guide physicians in the care of patients with acute arterial ischemic stroke. Additionally, the 2012 Lancet article “A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010” cited the longest outbreak duration (=5 years). This study suggests that in 2010, the three leading risk factors for the global disease burden were high blood pressure, tobacco smoking, and household air pollution from solid fuels (Lim et al., 2012).

Figure 9
www.frontiersin.org

Figure 9. References was co-cited for clustering (A) and the top 15 references with the strongest citation bursts (B).

3.8 Frequency and clustering analysis of keywords

Of the 3,625 keywords, 99 occurred at least 10 times and were analyzed further. If keywords had similar connotations, they were consolidated. Figure 10A illustrates the network visualization of these keywords, where the size of the nodes represents the keyword frequency and the proximity of the nodes signifies the strength of the relationships (Aria and Cuccurullo, 2017). Figure 10A presents a network visualization of these keywords. Group 1, depicted in green, concentrated on cardiocerebrovascular diseases linked to stroke, including atrial fibrillation, myocardial infarction, and “thrombosis.” Group 2, shown in blue, emphasized high-risk factors associated with cardiovascular diseases and meta-analyses, using keywords such as “cardiovascular disease,” “hypertension,” “obesity,” “diabetes,” and “meta-analysis.” The third light blue cluster primarily focused on epidemic risk factors associated with cardiovascular diseases, involving “cardiovascular disease,” “epidemiology,” “risk factors,” and “statistics.” Group 4 included the incidence, prevalence, and mortality rate of stroke-related diseases. Group 5, represented in red, centered on the pathogenesis of ischemic stroke with keywords such as “ischemic stroke,” “inflammation,” “oxidative stress,” and “neuroinflammation.” Figure 10B shows a visualization of the temporal overlapping of keywords.

Figure 10
www.frontiersin.org

Figure 10. (A) Keyword co-occurrence network; (B) time-overlapping co-occurrence analysis network of keywords; (C) the topic map; (D) the topic classification.

To reflect critical themes in stroke research, a topic map and topic classification of keywords were created (Figures 10C, D). The keywords “risk,” “outcome,” “meta analysis” are motor themes, have high density and high centrality, which are important and developing well at present. The keywords “stroke,” “mortality,” “risk-factors” belong to basic theme, have high centrality but less dense, which represent important but not well-developed in the research field. The keywords including “Alzheimer's disease,” “oxidative stress,” and “focal cerebral ischemia” belong to niche theme, have high density and low centrality, which means that they are well-developed but not important to the current field. The keywords “ischemic-stroke,” “acute ischemic-stroke,” and “double-blind” belong to emerging theme, have high centrality and low density. Combined with overlay visualization, this research field is relatively marginal; however, there has been a trend of emergence and development in recent years.

3.9 Analysis of keywords bursts

Figure 11 shows the 25 keywords with the highest citation bursts lasting for more than a year. The keywords “warfarin” (2014–2019), “inflammation” (2019–2024), and “expression” (2019–2024) have received the most consistent focus. Beyond “inflammation” “expression”, other keywords such as “brain” (2020–2024), “mechanisms” (2020–2024), “cell death” (2020–2024), “mechanical thrombectomy” (2020–2024), “health care professionals” (2020–2024), “thrombolysis” (2021–2024), “thrombectomy” (2021–2024), and “cells” (2020–2024) have also emerged recently. These findings suggest that future studies should focus on these areas.

Figure 11
www.frontiersin.org

Figure 11. The top 25 keywords with the strongest citation bursts.

4 Discussion

This study conducted a bibliometric review of 2,509 highly cited studies on stroke. The data indicate a consistent growth trend in the frequency of publications and the mean citation count for these pivotal works. From 2013 to 2023, the mean number of publications per annum among these influential articles was 227.73, with a corresponding annual citation average of 56.28. The gravity of stroke, as measured by its incidence, prevalence, case-fatality rate, and disability-adjusted life-years, underscores the enduring focus on stroke research by medical practitioners and public health professionals. Robust annual output within this scientific domain reflects this priority.

The top 10 nations, accounting for 82.66% of the referenced studies, are led by the United States, which contributes to a third (36.11%) of the total publications. The US also stands out for its international collaboration, leading seven of the top 10 slots in terms of collaborative frequency. These statistics underscore the US's preeminent role in global stroke research, a status likely attributable to its robust economic climate, significant investment in medical research, and prioritization of stroke studies. This field is poised to advance further through increased international scholarly collaboration, that is expected to enhance global research.

The top 10 academic institutions are largely distributed in the US, reflecting the country's prominent role in research output. While China leads in terms of the quantity of publications, none of its institutions are in the top 10. The UK holds the third position in terms of publications, with the University of Oxford coming in third with 116 papers in the top 10. Canada followed closely in fifth place, and the University of Toronto ranked fifth with 103 papers. Many collaborative studies have suggested that international partnerships are the key to enhancing research performance, particularly in resource-constrained environments.

Academic publishing relies heavily on peer-reviewed journals, which often conduct significant research within the field. Researchers can use the frequency of journal publications in the field of stroke to identify potential journals to submit their work. The New England Journal of Medicine tops the list with 223 publications, whereas Lancent has the highest impact factor (IF = 168.90), followed by the Journal of New England Journal of Medicine (IF = 158.50). Impact factor and journal citation reports (JCR) are standard metrics for assessing journal influence. JCR categorizes journals into quartiles (Q1–Q4) based on their IF, and all the top 10 journals by the number of papers are in the Q1 category. Furthermore, the top 10 journals are all based in the US and the UK, with the US accounting for 70% and the UK accounting for 30%.

The objective of this study was to address the topic of research extensively investigated by scholars over a defined period. The number of citations is considered a metric of a publication's academic impact (Xu and Sun, 2020). Publications with a high number of citations tend to encapsulate the core issues within a given research domain. Identifying these hotspots involves analyzing citation frequencies and pinpointing works that are frequently referenced. In this instance, nine articles qualified as highly cited (over 4,000 citations) and strongly linked (over 10 connections). These top-tier articles were published between 2015 and 2019 and predominantly appeared in the New England Journal of Medicine (four), Circulation (three), Lancet (one), and Stroke (one).

Three articles published in Circulation (Benjamin et al., 2017, 2018, 2019), penned by the American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee, collated the latest Figures on heart disease, stroke, and cardiovascular risk factors used in the AHA My Life Check. These articles were updated in 2017, 2018, and 2019 and were entitled “Heart Disease and Stroke Statistics.” The 2017 update emphasized the advantages of substantial blood pressure (BP) reduction in clinical trials (Benjamin et al., 2017), which reduced the risk of stroke outcomes. It also highlighted that adherence to a Mediterranean diet abundant in nuts and olive oil was associated with a lower risk of stroke. The 2018 update pointed out that there were significant racial and regional disparities in stroke risks and outcomes, with the impact of hypertension management on stroke risk being more significant in those receiving intense treatment (Benjamin et al., 2018). The 2019 update found that although age-standardized mortality rates for ischemic and hemorrhagic stroke worldwide decreased from 1990 to 2015, the actual number of annual stroke cases, related deaths, and disability-adjusted life years increased. The majority of the global stroke burden falls in low- and middle-income countries (Benjamin et al., 2019).

Four key studies were published in the New England Journal of Medicine, in 2015. Goyal et al. (2015) suggested that urgent endovascular treatment could improve functional recovery and reduce death rates in patients with acute ischemic stroke caused by a blocked main artery, limited brain damage, or sufficient blood flow through alternative routes. Campbell et al. (2015) demonstrated the advantages of early blood clot retrieval using the Solitaire FR stent retriever system, as opposed to using the clot-dissolving drug alteplase alone, in patients with ischemic stroke and signs of salvageable brain tissue on CT perfusion scans. Furthermore, Berkhemer et al. (2015) and his associates confirmed the effectiveness and safety of intra-arterial treatment within the first 6 h after stroke in patients with blockage of the main brain artery in the frontal circulation. Lastly, Sarafidis and Tsapas (Sarafidis and Tsapas, 2016) reported that patients with type 2 diabetes and were at high risk of cardiovascular issues who were treated with empagliflozin experienced a lower incidence of cardiovascular events and all-cause mortality when the medication was included in their standard care.

The 2016 findings from Goyal et al. (2016), published in The Lancet, indicated that endovascular thrombectomy can be advantageous for the majority of patients experiencing acute ischemic stroke due to blockage in the anterior circulation, regardless of individual patient traits or regional location. This has contributed to a shift in the treatment paradigm for acute ischemic stroke, which is caused by clot-blocking of blood vessels in the brain. Endovascular thrombectomy is a minimally invasive procedure that involves removal of the clot from the affected blood vessel using a catheter threaded through the arteries to the site of blockage.

In 2018, Powers et al. from the American Heart Association/American Stroke Association (Powers et al., 2019) Published A Guideline for Healthcare Professionals, Guidelines for the Early Management of Patients With Acute Ischemic Stroke, which are based on the best evidence currently available, guidelines detailing prehospital care, urgent and emergency evaluation and treatment with intravenous and intra-arterial therapies, and in-hospital management, including secondary prevention measures that are appropriately instituted within the first 2 weeks. These guidelines support the overarching concept of stroke care systems in both pre-hospital and hospital settings.

Because keywords affect the core content of a study, co-occurrence analysis can identify high frequency keywords that appear in different studies, thus helping researchers to quickly grasp research hotspots. The most frequently used keywords were “risk,” “stroke,” and “mortality.” The mean “stroke” frequency was 255. From the topic map and subject word classification results, we know that mortality and risk factors of stroke, as basic themes, are an important part of the research field; however, further research is required. Meta-analysis of stroke risk and outcome is a motor theme, has been performed extensively in this field and is relatively mature, and some related studies have been conducted on “Alzheimer's disease,” “oxidative stress,” and “focal cerebral ischemia,” but the subject area is less central, so the development in the subject field is currently less important. “Ischemic stroke,” “acute Ischemic stroke,” and “double-blind experiment” belong to emerging themes, because ischemic stroke has the highest incidence of all stroke types, and is expected to be one of the important research topics in this field in the future.

In the factor analysis, the top 50 keywords were divided into six major categories, with four major categories related to the center. The first classified topics are: fatal related factors, meta-analysis, mortality mechanism, epidemic trend of event occurrence, prevention strategies and other related topics. The second major category includes: risk factors for stroke and various causes of death, including cardiovascular disease, hypertension, and body mass index. The third category of topics was mainly divided into: ischemic stroke and acute ischemic stroke inflammation, acute myocardial infarction, randomized controlled trials, health care, and quality of life. These keywords are classified re?ect the core content of the stroke study.

The CiteSpace “burst detection” method identifies keywords or cited references with significant changes over time (Chen, 2006). Researchers can use keywords and cited references with burst features to explore hotspots. In this study, “inflammation,” “expression,” “mechanisms, “thrombolysis,” “thrombectomy,” and “cell” etc. were keywords that continued to burst as of 2024. This suggests that the pathogenesis of stroke, thrombolysis, and thrombectomy is a future research hotspot. In addition, one cited reference will continue to burst by 2024. The guidelines in this literature provide general recommendations based on currently available evidence to guide clinicians caring for adult patients with acute arterial ischemic stroke.

5 Conclusions

This article conducted a bibliometric analysis of 2,509 highly cited stroke research papers, revealing the current status and development trends in this field. The following is an in-depth exploration of the analysis results:

5.1 Research hotspots and future directions

Inflammation and thrombolytic therapy: the persistent burst of keywords such as “inflammation” and “thrombolysis” indicates that the pathogenesis of stroke, thrombolytic therapy, and thrombectomy will be the focus of future research. This suggests the need to further investigate the role of inflammation in the onset and development of stroke and develop more effective thrombolytic therapy strategies. Mechanism research: the burst of keywords such as “mechanism” and “cell” indicates that stroke researchers are increasingly focusing on studying the pathogenesis. This study provides a theoretical basis for the development of new therapeutic drugs and preventive strategies. Neuroimaging: the emergence of keywords such as “imaging” and “CT scan” suggests that neuroimaging techniques are becoming increasingly widely used in the diagnosis, evaluation, and treatment of stroke. In the future, it will be necessary to further develop and apply new imaging techniques to assess the pathophysiological changes and treatment effects of stroke more accurately. Personalized treatment: the emergence of keywords such as “gene” and “epigenetics” indicates that personalized treatment will become an important direction in stroke treatment. Further research is needed to investigate the role of genes and epigenetics in the pathogenesis of stroke to develop more precise treatment plans.

5.2 National and regional cooperation

The leading position of the United States in the field of stroke research is undeniable, with research output and influence ranking first globally. China ranks second in terms of research output; however, its research influence still needs to be improved, and international cooperation is an important way to improve the level of stroke research. There is extensive cooperation between developed countries, such as the United States, the United Kingdom, Germany, and Canada. In the future, it will be necessary to strengthen cooperation with other countries, especially developing countries, to jointly promote stroke research.

5.3 Research institutions and journals

Institutions such as Harvard Medical School and Brigham and Women's Hospital have made outstanding contributions to the field of stroke research, and their research results are of great significance in promoting the development of this field. Top journals such as the New England Journal of Medicine and The Lancet have published a large number of high-quality stroke research papers, playing an important role in promoting the development of this field.

5.4 Researcher influence

Researchers such as Yusuf S have made significant contributions to the field of stroke research, and their research results are of great significance in promoting the development of this field. In the future, more excellent stroke researchers need to be trained to promote the development of this field.

Stroke research is a field full of challenges and opportunities. In the future, we need to strengthen international cooperation, focus on research hotspots, and train outstanding stroke researchers to promote the development of this field and to make greater contributions to human health.

6 Strengths and limitation

This study had some limitations. First, it exclusively incorporates extensively highly cited English-language articles indexed in the WoSCC repository. Although WoSCC encapsulates the most premium research, it can potentially skew our findings. Second, the inclusion of recently released premium research may be compromised by a time lag in citations, necessitating future updates. Nonetheless, this study provides substantial aid to researchers in the field by offering insights into the progression, focal points, trends, and cutting-edge developments in stroke research as well as highlighting areas calling for additional investigation.

Author contributions

LF: Formal analysis, Resources, Software, Visualization, Writing – original draft. FS: Formal analysis, Supervision, Validation, Writing – review & editing. SW: Funding acquisition, Supervision, Validation, Writing – review & editing.

Funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.

Conflict of interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Publisher's note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.